X

Drug Profile

Ampiroxicam

Alternative Names: CP 65703; Flucam; Nacyl

Latest Information Update: 29 Oct 2018

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Pfizer
Developer FUJIFILM Toyama Chemical
Class Antirheumatics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines
Mechanism of Action Cyclooxygenase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Marketed Rheumatic disorders

Most Recent Events

01 Jul 2008 Toyama Chemical has been acquired by FUJIFILM Holdings Corporation
23 Jun 2000 Pfizer has merged with Warner-Lambert
07 Apr 2000 A study in rats has been added to the drug interactions section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com